Pages that link to "Q44085203"
Jump to navigation
Jump to search
The following pages link to Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. (Q44085203):
Displaying 50 items.
- Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved (Q21129279) (← links)
- Serotonin synthesis, release and reuptake in terminals: a mathematical model (Q21245218) (← links)
- Plasma membrane monoamine transporters: structure, regulation and function (Q22251021) (← links)
- Meta-analysis of molecular imaging of serotonin transporters in major depression (Q24289345) (← links)
- Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression (Q24611123) (← links)
- Comparison of the effects of estradiol and progesterone on serotonergic function (Q24614252) (← links)
- A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans (Q27114974) (← links)
- MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants (Q28293486) (← links)
- Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain (Q28730177) (← links)
- Early-life stress induces persistent alterations in 5-HT1A receptor and serotonin transporter mRNA expression in the adult rat brain (Q30439428) (← links)
- MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues (Q34166428) (← links)
- Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression (Q34212604) (← links)
- In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice (Q34292427) (← links)
- Differential mechanisms underlie the regulation of serotonergic transmission in the dorsal and median raphe nuclei by mirtazapine: a dual probe microdialysis study (Q34661038) (← links)
- Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. (Q34749301) (← links)
- Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders. (Q34917667) (← links)
- Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects (Q35012645) (← links)
- Ontogeny and regulation of the serotonin transporter: providing insights into human disorders (Q35090255) (← links)
- Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: Implications for fetal programming (Q35161157) (← links)
- Differential expression of 5-HT-related genes in symptomatic pulmonary embolism patients (Q35173508) (← links)
- Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM (Q35179035) (← links)
- Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans (Q35421231) (← links)
- Pathogenetic and therapeutic applications of microRNAs in major depressive disorder (Q35956471) (← links)
- Non-coding RNAs--novel targets in neurotoxicity (Q36292215) (← links)
- Serotonin transporters: implications for antidepressant drug development. (Q36341615) (← links)
- Neuroimaging research in human MDMA users: a review (Q36539089) (← links)
- RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis (Q36593806) (← links)
- The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia (Q36728829) (← links)
- A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation (Q37023193) (← links)
- Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tom (Q37156598) (← links)
- Genome-wide expression profiling of human lymphoblastoid cell lines implicates integrin beta-3 in the mode of action of antidepressants (Q37281179) (← links)
- Norepinephrine transporter regulation mediates the long-term behavioral effects of the antidepressant desipramine (Q37307278) (← links)
- Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs (Q37307331) (← links)
- Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats (Q37397245) (← links)
- Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine (Q37706110) (← links)
- Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. (Q38028902) (← links)
- Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions (Q38130498) (← links)
- MicroRNAs in neuronal communication. (Q38175350) (← links)
- Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration (Q38552025) (← links)
- Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). (Q38652284) (← links)
- Toward a multiscale modeling framework for understanding serotonergic function (Q39247652) (← links)
- Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression (Q43525141) (← links)
- Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems (Q44490449) (← links)
- Regulation of the norepinephrine transporter by chronic administration of antidepressants. (Q44742913) (← links)
- Transient neonatal jitteriness due to maternal use of sertraline (Zoloft). (Q44914122) (← links)
- Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey (Q45081793) (← links)
- Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram (Q46381665) (← links)
- Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome (Q46431252) (← links)
- siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain (Q46531749) (← links)
- Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. (Q46542652) (← links)